Beyfortus 49281-0574
Generic: Nirsevimab
Product NDC
49281-0574- Manufacturer
- Sanofi Vaccines Us Inc.
- Dosage Form
- Injection
- Route
- Intramuscular
- Product Type
- Human Prescription Drug
- Marketing Start
- July 18, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761328
Need to source Beyfortus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nirsevimab | 100 mg/mL |
Drug Class
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]Fusion Protein Inhibitors [MoA]Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]
Packaging Options(2)
5 SYRINGE in 1 CARTON (49281-574-15) / 1 mL in 1 SYRINGE
1 SYRINGE in 1 CARTON (49281-574-88) / 1 mL in 1 SYRINGE